News US lawmakers seek ban on DTC advertising US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by the pharma industry.
Sales & Marketing Trump and RFK promised to ban D2C pharma advertising. Pharma... The idea that the US might join peers around the world in banning direct-to-consumer advertising is one that the pharma industry is taking seriously.
News Lilly launches discounted high-strength Zepbound vials in US Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.
News Lawmakers seek answers on Pfizer, Lilly telehealth moves US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws.
News Pfizer joins Lilly in direct-to-consumer drive Pfizer has become the latest big pharma group to launch a web-based platform that opens up a direct-to-consumer channel for medicines access.
Digital Can creative analytics solve your D2C paid search headache? Digitalisation has forever changed how we engage with healthcare.
Market Access Policy in focus: Trump’s Most Favoured Nations drug pricing ... Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.